In the present study, thromboviscometry was used to analyse the dynamic coagulation of blood in patients with severe systemic hypertension. Fibrinogen levels and whole blood viscosity, corrected for 45% haematocrit, were also monitored. The efficacy of thromboviscometry as an adjunct diagnostic tool, for determination of thrombogenic potential, was compared with that of detection of fibrinogen levels in the blood. Twenty-five cases of severe systemic hypertension (HT) in the 40 to 50-year age group were compared with 50 age and sexmatched normal controls (NC). The changes in whole blood viscosity were monitored with time at a constant shear rate, in a concentric cylinder viscometer, during the clotting process. The total thrombus formation time was significantly less in the HT group when compared with NC (238.9 ± 38.72 s vs 315.1 ± 32.93 s, P Ͻ 0.0005).
Introduction
Hypertension is not solely a phenomenon of elevation of systemic blood pressure. It frequently occurs in association with a great deal of metabolic derangements. 1 Although the blood vessels are exposed to high pressures in hypertension, the main complications of hypertension (stroke and myocardial infarction) are paradoxically thrombotic rather than haemorrhagic. 2 Conventional risk factors predict only about 30-50% of incidental cases in cardiovascular diseases, 3 which are still the leading cause of death in Western societies and are increasingly causing more and more mortality in developing countries with changes in lifestyle.
In keeping with Virchow's triad, patients with hypertension do demonstrate abnormalities of vessel wall (endothelial dysfunction or damage), blood constituents (abnormal levels of haemostatic factors, platelet activation and fibrinolysis) and blood flow (rheology and flow reserve), suggesting that hypertension does confer a prothrombotic or hypercoagulable state. 4 These abnormalities appear to be related to target organ damage and long-term prognosis and
The time required for a sudden increase in viscosity during clotting was also significantly lower in the HT group (205.9 ± 34.37 s vs 272.9 ± 28.83 s, P Ͻ 0.0005) and the overall rate of increase of thrombus viscosity was significantly higher in HT (245.2 ± 36.44 centiPoise/s vs 183.6 ± 16.32 centiPoise/s, P Ͻ 0.0005). There was, however, no significant change in the fibrinogen levels of the two groups. Thus, thromboviscometry was a more sensitive indicator of the thrombogenic potential of blood in HT than fibrinogen levels. The increased thrombogenic potential of hypertensive blood could be due to acceleration of the initial part of the coagulation process during the activation of factor Xa and the formation of thrombin. Journal of Human Hypertension (2000) 14, [105] [106] [107] [108] [109] are altered by treatment. The observation that satisfactory blood pressure reduction, with non-drug intervention and with various classes of antihypertensive drugs, does not lead to a corresponding reduction in heart attacks and strokes may be due in part to the unfavourable effects of the hypercoagulable state in hypertension. There is a need to regularly monitor the hypercoagulable state of hypertension to detect cases 'at risk' of future thrombotic complications.
Coagulation is a dynamic process. The conventional coagulation tests are static end-points of this continuous process. For accurate information regarding the coagulation process, a dynamic test which continuously monitors the process of thrombus formation is required. Thromboelastography is one such method which has been used experimentally since 1948. It is based on the principle of an increase in the elastic shear modulus of blood with time during the process of coagulation. 5 However, very few studies have utilised the changes in whole blood viscosity for monitoring the coagulation process. Liao et al 6 described the use of a rotational viscometer for rheological analysis of thrombus formation. The present study investigates the thrombogenic potential of hypertensive blood by using a modification of this method of thromboviscometry.
Thromboviscometry was used as the technique for comparison of the coagulability of the blood of hypertensive patients vs that of normals by in vitro rheological experiments. This was done by studying the changes in the whole blood viscosity after subjecting the blood samples to a constant shear rate in a concentric cylinder viscometer. Figure 1 depicts a schematic representation of a concentric cylinder viscometer. It is a co-axial cylinder viscometer having the cylinders in the form of a bob (inner cylinder) and a cup (outer cylinder). The cup holds volumes as low as 1 ml and hence this instrument is particularly suited for rheological measurements of biological samples. The sample is placed in the cup and the bob is positioned in the centre of the cup so that the blood sample occupies the space in between the two cylinders. The temperature-regulated, interchangeable measuring cup can be rotated at a given speed by a speed-controlled motor. The measuring cup of the coaxial system, rotating at accurately defined speeds, exerts a torque on the measuring bob through the test substance. The torque transmitted to the inner cylinder or bob is proportional to the viscosity or resistance to rotation offered by the sample. The torque experienced by the inner cylinder or bob is recorded which gives an estimate of the sample viscosity on multiplication by predetermined factors. An acute or chronic increase in fibrinogen levels can lead to thrombotic complications, by infiltration of the vessel wall, by rheological effects due to an increase in blood and plasma viscosity, by increased platelet aggregation and fibrin formation. 7 Thus, fibrinogen levels were also measured in our study, as a measure of the hypercoagulability of hypertensive blood. The confounding effects of increased haematocrit on whole blood viscosity were ruled out by comparing the corrected whole blood viscosity, for 45% haematocrit, between the two groups. The sensitivity of thromboviscometry was compared to that of monitoring of fibrinogen levels, as an assay for prediction of a hypercoagulable state. 
Materials and methods

Patient selection
Twenty-five cases of severe hypertension were considered for the present study. The patients were in the 40 to 50-year age-group. The WHO definition of hypertension (BP Ͼ160/95 mm Hg) was strictly adhered to and patients who were hypertensive for the past 5 years with no complications of high blood pressure were selected for the hypertensive group. All hypertensives were on similar antihypertensive drugs for the past 5 years-a combination of diuretic and a beta-blocker. Hence, this patient group (HT) consisted of severely uncontrolled hypertensives with high blood pressure in spite of treatment. A detailed clinical examination was conducted in all the hypertensive patients to rule out any underlying disorders which could act as confounding factors. Fifty age and sex-matched normotensive individuals who were free from any diseases for the last 5 years and were clinically normal on examination were selected for the control group of normals (NC).
Experimental method
For thromboviscometry: Two cm 3 of blood was freshly collected from the antecubital vein of the subjects and analysed immediately (within 5 sec) without any anticoagulation. The blood samples were subjected to a constant shear rate of 0.512/s in a concentric cylinder viscometer (Contraves LS 30 viscometer) and the changes in whole blood viscosity were recorded as a function of time. The recordings were taken at 2-sec intervals and continued till a maximum viscosity was reached, which remained stable for at least 6 sec, when the coagulation process was said to be complete and this was confirmed by gross examination of the thrombus formed. The viscosity changes were plotted against time to generate the thrombograph. The following parameters were calculated from the thrombographs: r:
(in seconds) the latent clotting timemeasured from the moment when the blood was poured into the cup of the Contraves viscometer to the moment when there was a sudden increase in the blood viscosity; s:
(in seconds) the thrombus formation time-measured from the moment of sudden increase in blood viscosity to the moment when the maximum viscosity of the thrombus was reached r + s: (in seconds) the total thrombus formation time-a sum of the latent clotting time and the thrombus formation time; A r :
(in centiPoise) the viscosity at time 'r'; A r+s :
(in centiPoise) the maximum apparent viscosity of the thrombus; ⌬A:
(in centiPoise) the change in viscosity during time 's'-the difference between A r+s and A r ; A r/r :
(in centiPoise/second) the rate of change of viscosity during initial period of clotting; ⌬A/s: (in centiPoise/second) the rate of change of viscosity during the period of steep rise in viscosity A r+s /(r+s): (in centiPoise/second) the rate of thrombus formation.
For fibrinogen estimation and study of hemorheology: Blood samples (6 cm 3 ) were collected from the subjects in the fasting state from the antecubital vein with the help of a disposable syringe and anticoagulated with EDTA (1.8 mg/ml blood). The blood samples were kept at a constant bath temperature at 37°C and were tested within 2 h of venepuncture. Fibrinogen levels were estimated by the modified Ratnoff and Manzie method, 8 described here in brief. Fibrinogen in plasma was converted into fibrin which was estimated using Folin-Ciocalten Phenol reagent. Anticoagulated blood was centrifuged at 1000 rpm for 10 min. Six ml of distilled water and 0.2 ml of calcium chloride were added to 0.2 ml plasma. After overnight refrigeration, samples were centrifuged at 3000 rpm for 15 min. After separation of the supernatant, the clot was washed thrice with saline and the saline was rinsed out. One ml (100 g/l) NaOH was added to the washed clot and the sample was incubated in a boiling water bath for 15 min. After cooling to room temperature, 7 ml of water, 3 ml of Na 2 CO 3 (200 g/l) and 1 ml of Folin reagent were added to the suspension. Absorbance was read at 650 nm wavelength on Shimadzu UV visible spectrophotometer.
Whole blood viscosity was measured at a shear rate of 20.4/s in a concentric cylinder viscometer (Contraves LS30 viscometer). 9 To avoid the confounding effects of a haematocrit on whole blood viscosity, the corrected whole blood viscosity for Journal of Human Hypertension 45% hematocrit was compared between the hypertensive and normal groups.
All data were analysed using Student's t-test and P values were calculated for determination of statistical significance. A P value Ͻ0.05 was taken as the cut off for statistical significance.
Results
Figure 2 depicts representative thrombographs of hypertensive and normotensive individuals and defines the parameters calculated. Table 1 shows the values of the various parameters obtained from the thrombographs of the HT group and compares them with those of the NC group. The total thrombus for- The values of the whole blood viscosity corrected to 45% haematocrit and the fibrinogen levels are shown in Table 2 . The corrected whole blood viscosity was significantly higher in the HT group than NC (P Ͻ 0.005) which rules out an increase in haematocrit as the sole cause of the hyperviscosity and hypercoagulability of hypertensive blood. On comparing the fibrinogen levels, it was observed that there was no significant difference in the levels of the two groups. Thus, thrombovioscometry proved a more sensitive indicator of hypercoagulability in hypertensives than the standard method of fibrinogen detection.
The change in viscosity during coagulation was found to increase suddenly from time 'r' till the achievement of the maximum viscosity of the thrombus. The curve of viscosity vs time till the point (r + s) was found to follow an exponential curve. Both the hypertensive and normal curves followed exponential growths in thrombus viscosity till the point of reaching the maximum viscosity. The viscosity stabilised at this point for a few seconds where the present experiment was concluded. However, further analysis would reveal a decrease in the maximum viscosity due to fibrinolysis. Since the present study was specifically directed towards the investigation of the thrombogenic potential of hypertensive blood, the curve only till the point of (r + s) was considered. Figures 3 and  4 depict the fitted curves of the hypertensives and normals respectively. It was observed that the thrombograph of hypertensives followed an exponential growth in accordance with the equation y = 11.887 e 0.0334x , with a coefficient of regression (R 2 ) of 0.75, where y is the quantity on the y axis, ie, viscosity and x is the quantity on the x axis, ie, time. The thrombograph of normals also followed an exponential growth in accordance with the equation y = 11.887 e 0.0237x , with a coefficient of regression (R 2 ) of 0.80, where y is the quantity on the y axis, ie, viscosity and x is the quantity on the x axis, ie, time. Thus, mathematically also, it was observed that the exponential growth of the thrombus viscosity of the hypertensive group was higher than that of the normals. This increase in hypercoagulability was highly reproducible as was evidenced by the significant increase in the diseased thrombograph parameters when compared with standard thrombograph values obtained for a large number of normal individuals (50) and the low standard deviations obtained.
Discussion
The present study found significant increases in the thrombogenic potential of hypertensive blood compared to that of normotensive individuals. However, levels of fibrinogen failed to detect this difference. This was contrary to the finding of Lip et al 2 and Imperatore et al 10 that the diastolic blood pressure could be correlated with plasma fibrinogen levels.
The increased thrombogenic potential of hypertensive blood could be due to acceleration of the initial part of the coagulation process during the activation of factor Xa and the formation of thrombin. This would explain the significant decrease in the value of 'r', as obtained from the thrombograph, in HT group when compared with NC. Also there appeared to be no significant change in the time required for generation of the fibrin polymer after activation of factor Xa -thus, there was no significant difference in the values of 's', as obtained from the thrombograph, between the two groups. Further, there was no significant difference in the maximum viscosity reached during coagulation in the two groups. This would indicate that there was no difference in the structural integrity of the thrombus formed and the increased thrombotic potential of hypertensives was solely due to acceleration of the initial part of the coagulation process. The overall increased rate of thrombus formation in HT was further confirmed by the comparison of the equations followed during the exponential growth of thrombus viscosity of the two groups.
Thus, thromboviscometry could prove a useful clinical assay for evaluation of the thrombotic risk of hypertensives. It requires only 2 cm 3 of blood, is easy to perform, can be used for bedside analysis, provides quick results within 30 min and may offer advantages over conventional measures of haemostatic function. Regular monitoring of the blood of hypertensives by this technique could help evaluate the increased thrombotic risk of the patient. Severe systemic hypertension is, of course, only one example of the possible uses of thromboviscometry in detection of hypercoagulability. The favourable findings of this study now opens up the possibility of using thromboviscometry for detection of hypercoagulability in other cardiovascular diseases like myocardial infarction and peripheral atherosclerosis. Further research is being carried out in our laboratory, to investigate the specificity of this technique in various other cardiovascular conditions which would further validate the usefulness of this technique. This could be a vital step in the prevention of future complications by timely interventions directed towards correcting the underlying haemorheological abnormalities and reversing the hypercoagulable state. However, further research in the form of follow-up studies is required to validate the prognostic usefulness of this technique.
